Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Horvath

Showing results (181-190 of 279) with videos related to

Pageof 28
Sort By:
Cancers|June 3, 2020
Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate CancerDushan Miladinovic, Thomas Cusick, Kate L Mahon, et al.
The Prostate|March 26, 2004
Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progressionLisa G Horvath, Susan M Henshall, James G Kench, et al.
International Journal of Cancer|September 30, 2004
Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancerLisa G Horvath, Susan M Henshall, C-Soon Lee, et al.
BMJ Open|January 29, 2020
Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer)Tahlia Scheinberg, James Kench, Martin Stockler, et al.
British Journal of Cancer|August 15, 2019
p53 nuclear accumulation as an early indicator of lethal prostate cancerDavid I Quinn, Phillip D Stricker, James G Kench, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 15, 2023
Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important ChangesTiffany Li, Hannah C Timmins, Terry Trinh, et al.
The Journal of Pathology|March 26, 2021
Inhibition of guanosine monophosphate synthetase (GMPS) blocks glutamine metabolism and prostate cancer growthQian Wang, Yi Fang Guan, Sarah E Hancock, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 3, 2024
Evaluating a shared care pathway intervention for people receiving chemotherapy to reduce post-treatment unplanned hospital presentations: a randomised controlled trialJudith Fethney, Bora Kim, Chantale Boustany, et al.
JCO Precision Oncology|July 29, 2024
Circulating Lipid Profiles Associated With Resistance to Androgen Deprivation Therapy in Localized Prostate CancerHui-Ming Lin, Xiaoyu Yang, Margaret M Centenera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2017
A prospective multicentre phase III validation study of AZGP1 as a biomarker in localized prostate cancerA Y Zhang, J S Grogan, K L Mahon, et al.
Pageof 28

Showing results (181-190 of 279) with videos related to

Sort By:
Pageof 28
Cancers|June 3, 2020
Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate CancerDushan Miladinovic, Thomas Cusick, Kate L Mahon, et al.
The Prostate|March 26, 2004
Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progressionLisa G Horvath, Susan M Henshall, James G Kench, et al.
International Journal of Cancer|September 30, 2004
Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancerLisa G Horvath, Susan M Henshall, C-Soon Lee, et al.
BMJ Open|January 29, 2020
Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer)Tahlia Scheinberg, James Kench, Martin Stockler, et al.
British Journal of Cancer|August 15, 2019
p53 nuclear accumulation as an early indicator of lethal prostate cancerDavid I Quinn, Phillip D Stricker, James G Kench, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 15, 2023
Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important ChangesTiffany Li, Hannah C Timmins, Terry Trinh, et al.
The Journal of Pathology|March 26, 2021
Inhibition of guanosine monophosphate synthetase (GMPS) blocks glutamine metabolism and prostate cancer growthQian Wang, Yi Fang Guan, Sarah E Hancock, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 3, 2024
Evaluating a shared care pathway intervention for people receiving chemotherapy to reduce post-treatment unplanned hospital presentations: a randomised controlled trialJudith Fethney, Bora Kim, Chantale Boustany, et al.
JCO Precision Oncology|July 29, 2024
Circulating Lipid Profiles Associated With Resistance to Androgen Deprivation Therapy in Localized Prostate CancerHui-Ming Lin, Xiaoyu Yang, Margaret M Centenera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2017
A prospective multicentre phase III validation study of AZGP1 as a biomarker in localized prostate cancerA Y Zhang, J S Grogan, K L Mahon, et al.
Pageof 28